Apr 9, 2022 | Access, Featured
WASHINGTON — Patients Rising Now Executive Director Terry Wilcox today released the following statement in response to CMS’ final decision to restrict access to FDA-approved Alzheimer’s treatments to clinical trial participants: “It’s a sad day for the millions...
Read more
Jul 22, 2021 | Federal Issues
FDA Must Step Up Oversight of Hand Sanitizer Safety By Marlene Wüst Smith, MD Hand sanitizer – it’s the go-to item for protecting our kids, even our “big” kids, those attending college in person. We keep it in our cars, our briefcases, kids’ backpacks, and our...
Read more
Jun 27, 2021 | Featured, Federal Issues, Podcast
On this episode of the podcast, Terry and Bob discuss the FDA’s advisory committees, which help the agency decide how to make its approval decisions. Three committee members recently resigned following the FDA’s approval of Aduhelm, the first new...
Read more
Apr 26, 2021 | COVID-19, Featured, Federal Issues
On this episode of the podcast, Terry and Bob discuss the Food and Drug Administration and its lessons learned from the pandemic. They highlight how best practices from Operation Warp Speed and research on Covid-19 long haulers can inform ongoing treatments for those...
Read more
